Skip to Content

a KA (Kaletra 200 mg / 50 mg)

Generic Name: lopinavir/ritonavir

Pill imprint a KA has been identified as Kaletra 200 mg / 50 mg.

Kaletra is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 200 mg / 50 mg is not a controlled substance under the Controlled Substance Act (CSA).

Kaletra 200 mg / 50 mg a KA  Front
Kaletra 200 mg / 50 mg a KA  Back
Kaletra 200 mg / 50 mg a KA
Discount Card Promo
Generic Name:
a KA
200 mg / 50 mg
19.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Abbott Laboratories
National Drug Code (NDC):
Inactive Ingredients:
sorbitan monolaurate
silicon dioxide colloidal
sodium stearyl fumarate
titanium dioxide
polyethylene glycol 400
hydroxypropyl cellulose
magnesium silicate
polyethylene glycol 3350
ferric oxide yellow
polysorbate 80

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5752 A-S Medication Solutions, LLC (repackager)
54868-5566 Physicians Total Care Inc (repackager)
55045-3482 Dispensing Solutions Inc. (repackager)
55289-0947 PDRX Pharmaceuticals Inc (repackager)
35356-0112 Lake Erie Medical and Surgical Supply (repackager)
21695-0362 Rebel Distributors Corp (repackager)
68258-1972 Dispensing Solutions Inc. (repackager)
66336-0624 Dispensing Solutions Inc. (repackager)
68071-0748 Nucare Pharmaceuticals Inc (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.